SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (736)5/13/1997 10:00:00 AM
From: Lee Warzala   of 6136
 
I think you are on the money, margie. So far, there have been 9 Form 4 filings. There will be at least 5 more in the coming days. Here is a breakdown of activity for the 9 filings.

Cowell- Sold 5K then exercised 5K in options.
Johnson (our hero)- Sold 15K then excercised 34,555 in options.
Jackson- Sold 3K then excercised 3K in options.
Cowell- Sold 5K.
Simon- Sold 5K.
Cowell- Excercised 5K in options.
Knoppers- Sold 3K.
Cowell- Excercised 5K in options.
Knoppers- Sold 3K.

The majority of the the transactions took place at or just before tax day.
So far (but this could change with upcoming reports) Knopper is the only director showing a net decline in holdings.
So far for April, the directors have acquired 52,555 and sold 39,000 for a net increase in holdings of 13,555 shares.
A very approximate dollar number: They sold $3,000,000 in stock and bought all of it back (and then some) for $500,000.
It seems to me that their transactions increased their net worth by about $900,000. On the other hand, the drop in the stock price cost them $630,000. Thus for $270,000 the ticked off a lot of long term investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext